Back to Search
RHEA FINN, PHARMD, RPH
PHARMD, RPH
Pharmacist
NPI: 1003410093Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
PMID 19374603·Expert Rev Anticancer Ther·2009
6-review
Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway.
PMID 18778245·Biochem J·2009
7-preclinical
Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.
PMID 18482274·Liver Int·2009
4-observational
Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.
PMID 18805792·J Biol Chem·2008
7-preclinical
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.
PMID 17268817·Breast Cancer Res Treat·2007
8-other
Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system.
PMID 17435107·J Pharmacol Exp Ther·2007
7-preclinical
Identification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1.
PMID 15900210·Pharmacogenet Genomics·2005
8-other
Genomic and proteomic analyses reveal non-neofunctionalized vitellogenins in a basal clupeocephalan, the Atlantic herring, and point to the origin of maturational yolk proteolysis in marine teleosts.
PMID 19174481·Mol Biol Evol·2009
7-preclinical
A phase I/II trial of trastuzumab plus erlotinib in metastatic HER2-positive breast cancer: a dual ErbB targeted approach.
PMID 19299235·Clin Breast Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 BASSETT ST
MILTON, MA 02186 - Phone
- (617) 698-2805
Quick Facts
- NPI
- 1003410093
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile